With innovative immune cell therapy
Fight against hopelessness
Headquartered in Daejeon, South Korea, Curocell is a biotechnology company discovers and develops the innovative CAR-T therapies for cancer. We identify and focus on therapeutic solutions that have the potential to save the lives of the millions of cancer patients worldwide.
Our current efforts focus on unleashing the body’s immune system through broad-spectrum CAR-T technologies to treat blood cancers, as well as the solid cancers. Our programmed T cell product candidates are differentiated by incorporation of T cell modifying technology designed to effectively overcoming the immune suppression, and thereby offers greater efficacy compared to the current CAR-T cell technology.
48, Yuseong-daero 1184 beon-gil,
Republic of Korea
For more information about Curocell, please complete the form below.